Company Description
Quantum Genomics (OTC Link: QNNTF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $7.0M.
QNNTF stock has declined 97.1% over the past year.
This page provides a comprehensive overview of QNNTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Quantum Genomics (QNNTF) stock. Over the past 12 months, the stock has lost 97.1%. At a market capitalization of $7.0M, QNNTF is classified as a micro-cap stock with approximately 69.7M shares outstanding.
Latest News
Quantum Genomics has 10 recent news articles. Key topics include clinical trial, earnings, management. View all QNNTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Quantum Genomics (QNNTF) currently stands at 819 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Quantum Genomics (QNNTF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
QNNTF Company Profile & Sector Positioning
Quantum Genomics (QNNTF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing QNNTF often look at related companies in the same sector, including Bioxytran Inc (BIXT), Glow Lifetech (GLWLF), Sigyn Therapeutics Inc (SIGY), Pharmala Biotech (MDXXF), and Pathnet Inc (PTNT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QNNTF's relative position within its industry.